Caffeine has been shown to modulate the balance of proinflammatory and anti-inflammatory factors in vivo, such as the concentrations of interleukin 6 and interleukin 10 (47), which may alter the inflammatory microenvironment of the prostate and thus further participate in the development of BPH. The gene discussed is IL10; the disease is benign prostatic hyperplasia.